EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance

Ahmed S Doghish, Maghawry Hegazy, Ahmed Ismail, Hesham A El-Mahdy, Elsayed G E Elsakka, Samy Y Elkhawaga, Mohamed A Elkady, Amr Mohamed Yehia, Nourhan M Abdelmaksoud, Mahmoud Mohamed Mokhtar

Pathology - Research and Practice · 2023

DOI: 10.1016/j.prp.2023.154442 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Ahmed S Doghish und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Cairo 11829, Egypt; Biochemistry and Molecular Biology De…. Hauptthemen laut MEDLINE: MicroRNAs, Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 266 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is one of the most common bone cancers that constantly affects children, teenagers, and young adults. Numerous epigenetic elements, such as miRNAs, have been shown to influence OS features like progression, initiation, angiogenesis, and treatment resistance. The expression of numerous genes implicated in OS pathogenesis might be regulated by miRNAs. This effect is ascribed to miRNAs' roles in the invasion, angiogenesis, metastasis, proliferation, cell cycle, and apoptosis. Important OS-related mechanistic networks like the WNT/b-catenin signaling, PTEN/AKT/mTOR axis, and KRAS mutations are also affected by miRNAs. In addition to pathophysiology, miRNAs may influence how the OS reacts to therapies like radiotherapy and chemotherapy. With a focus on how miRNAs affect OS signaling pathways, this review seeks to show how miRNAs and OS are related.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsOsteosarcomaBone NeoplasmsAdolescentChildYoung AdultHumansDrug Resistance, NeoplasmCell ProliferationWnt Signaling PathwayCell Line, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Oncogenic miRNAsOsteosarcomaResistanceTumor suppressor (TS) miRNAs

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Cairo 11829, Egypt; Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr City 1…
  • Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr City 11231, Cairo, Egypt.
  • Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr City 11231, Cairo, Egypt. Electronic address: heshamabbas@azhar.edu.eg.
  • Department of Biochemistry, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt.

Zitieren

APA

Doghish, A. S., Hegazy, M., Ismail, A., El-Mahdy, H. A., Elsakka, E. G. E., Elkhawaga, S. Y., Elkady, M. A., Yehia, A. M., Abdelmaksoud, N. M., & Mokhtar, M. M. (2023). A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154442

Vancouver

Doghish AS, Hegazy M, Ismail A, El-Mahdy HA, Elsakka EGE, Elkhawaga SY, et al. A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154442

BibTeX
@article{Doghish2023,
  author = {Doghish, Ahmed S and Hegazy, Maghawry and Ismail, Ahmed and El-Mahdy, Hesham A and Elsakka, Elsayed G E and Elkhawaga, Samy Y and Elkady, Mohamed A and Yehia, Amr Mohamed and Abdelmaksoud, Nourhan M and Mokhtar, Mahmoud Mohamed},
  title = {A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance},
  journal = {Pathology - Research and Practice},
  year = {2023},
  doi = {10.1016/j.prp.2023.154442}
}
Kostenlos starten →